Key result
Multimodality imaging identifies underlying ATTR cardiomyopathy with 48% ECV despite resolved acute pericarditis.
Why the study?
When a concurrent treatable diagnosis like pericarditis is identified, symptomatic improvement may cause premature diagnostic closure and failure to test for underlying infiltrative cardiomyopathy.
Case Report (n=1)
Persistent imaging red flags such as apical sparing on strain and elevated extracellular volume should prompt definitive testing for infiltrative cardiomyopathy even if symptoms resolve after treating a concurrent condition like pericarditis.
Avoid premature closure after treating pericarditis in troponin-positive non-obstructive CAD; leaves open need for CMR to exclude amyloidosis.
Background Cardiac amyloidosis can present with troponin-positive chest pain and non-obstructive coronary arteries, mimicking acute coronary syndrome (ACS). When a concurrent treatable diagnosis such as pericarditis is identified, symptomatic improvement may lead to premature diagnostic closure and failure to pursue confirmatory testing for an underlying infiltrative cardiomyopathy. Case Summary A man in his 70s presented with pleuritic chest pain and troponin-T of 1,840 ng/L. Coronary angiography was normal. Echocardiography revealed left ventricular hypertrophy with apical sparing on longitudinal strain. Cardiac magnetic resonance (CMR) showed diffuse subendocardial late gadolinium enhancement and elevated extracellular volume (48%). 18F-FDG-PET confirmed active pericarditis but no myocardial inflammation. Endomyocardial biopsy confirmed amyloid deposits; Tc-99m-PYP scintigraphy confirmed ATTR cardiomyopathy. He was treated for myopericarditis and referred for ATTR therapy. Discussion This case highlights how symptomatic resolution after treatment of acute pericarditis can obscure a co-existing infiltrative cardiomyopathy, and why persistent imaging red flags, including apical sparing on strain, diffuse subendocardial late gadolinium enhancement, and markedly elevated extracellular volume, should prompt definitive testing regardless of clinical improvement.
No takes yet. Share an insight, caveat, or question.
Kocx et al. (2026) conducted a case report in ATTR cardiomyopathy and pericarditis (n=1). Multimodality imaging identified underlying ATTR cardiomyopathy with an elevated extracellular volume of 48% in a patient despite symptomatic resolution of acute pericarditis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: